Scientific Director
GSK
Pharmaceuticals Development leader with 17 years of experience in the design and development of medicines from early to late / commercial phases of development. Background in Chemometrics & Process Technologies. Currently leads the Process Modelling group at GSK across small and large molecule drug substance and drug product portfolio in the UK. Supported numerous filings and technical transfers including the first GSK product developed under the QbD paradigm, respiratory medicines and the first drug substance and drug product developed and manufactured using continuous processing.